(CC) To date, we have treated one patient with dry AMD at UCLA and a total of four patients with SMD, three at UCLA and one at Moorefield Eye Hospital in London.
Lancet was published on Jan 23 so that the latest patient to be treated would be early to mid Feb. It could only be the 2nd AMD in the first Cohort
It would sure be nice to get a little more transparency on where we really stand on our AMD clinicals and the status of any negotiations with the FDA on a possible AMD trial re-design.